lobbying_activities: 1996301
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1996301 | 6c606795-50f4-4ab0-9395-23ec8e4365a4 | Q2 | BUCHANAN INGERSOLL & ROONEY PC | 55291 | TONIX PHARMACEUTICALS HOLDING CORP. | 2017 | second_quarter | PHA | Federal funding related to clinical trials for military PTSD; FY 2018 NDAA and Defense Appropriations | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2017-07-19T13:30:43.243000-04:00 |